1Natsume A, Yoshida J. Gene therapy for glioma. Shinkei Kenkyu no Shinpo (Japanese), 1999, 43(3): 359-402.
2Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-produce cells for treatment of experimental brain tumors. Science, 1992, 256: 1550-1552.
3Freeman SM, Ramesh R, Marrogi AJ. Immune system in suicide-gene therapy. Lancet, 1997, 349: 2-3.
4Beltinger C, Fulda S, Kammertoens T, et al. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci USA, 1999, 96: 8699-8704.
5Ram Z, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector producing cells. Nat Med, 1997, 3: 1354-1361.
6Chen SH, Shine HD, Godman JC, et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA, 1994, 91: 3054-3057.
7Mizuno M, Yoshida J, Colosi P, et al. Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human glioma in mice, in conjugation with ganciclovir administration. Jpn J Cancer Res, 1998, 89: 76-80.
9Sobol RE, Fakhrai H, Shawler D, et al. Inteeleukin-2 gene therapy in a patient with glioblastoma. Gene Ther,1995, 2:164-167.
10Trojan J, Johnson TR, Rudin SD, et al. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor 1 RNA. Sience,1993, 259: 94-97.
10Deorah S, Lynch CF, Slibebenaller ZA, et al. Trends in brain cancer incidence and survival in the United States: Sur- veillance, Epidemiology, and End Resultes Program, 1973 to 2001 [J]. NeurosurgFocus. 2006, 20 (4) El.
